Bristol Myers Squibb (BMY) Income from Non-Controlling Interests (2016 - 2025)
Historic Income from Non-Controlling Interests for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$6.0 million.
- Bristol Myers Squibb's Income from Non-Controlling Interests fell 25000.0% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 4545.45%. This contributed to the annual value of $15.0 million for FY2024, which is 0.0% changed from last year.
- Per Bristol Myers Squibb's latest filing, its Income from Non-Controlling Interests stood at -$6.0 million for Q3 2025, which was down 25000.0% from $2.0 million recorded in Q2 2025.
- In the past 5 years, Bristol Myers Squibb's Income from Non-Controlling Interests registered a high of $8.0 million during Q1 2021, and its lowest value of -$6.0 million during Q3 2025.
- Its 5-year average for Income from Non-Controlling Interests is $4.1 million, with a median of $4.0 million in 2023.
- In the last 5 years, Bristol Myers Squibb's Income from Non-Controlling Interests surged by 20000.0% in 2023 and then crashed by 25000.0% in 2025.
- Over the past 5 years, Bristol Myers Squibb's Income from Non-Controlling Interests (Quarter) stood at $6.0 million in 2021, then plummeted by 50.0% to $3.0 million in 2022, then skyrocketed by 100.0% to $6.0 million in 2023, then tumbled by 33.33% to $4.0 million in 2024, then tumbled by 250.0% to -$6.0 million in 2025.
- Its last three reported values are -$6.0 million in Q3 2025, $2.0 million for Q2 2025, and $6.0 million during Q1 2025.